Streptomyces catenulae Davisson and Finlay (ATCC® 12476)

Strain Designations: 5541-6A [ATCC 23893, CBS 679.68, IFO 12848, ISP 5258, KCC S-0353, Pfizer 6563, RIA 1183]  /  Type Strain: yes  /  Biosafety Level: 1

Strain Designations 5541-6A [ATCC 23893, CBS 679.68, IFO 12848, ISP 5258, KCC S-0353, Pfizer 6563, RIA 1183]
Application
Produces paromomycin aminosidine, catenulin
Produces pepsinostreptin N-isobutyrylpepstatin
Production of pepsinostreptin complex
Isolation
Soil
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain yes (type strain)
Comments
Streptomyces griseoluteus
Name of Depositor Chas. Pfizer & Co., Inc.
Isolation
Soil
References

Kakinuma A, et al. Pepsinostreptins, novel protease inhibitors from Streptomyces. US Patent 3,907,764 dated Sep 23 1975

Davisson JW, Finlay AC. Catenulin and its production. US Patent 2,895,876 dated Jul 21 1959

. . Bergey's Manual Syst. Bacteriol. 4: 2479, 1989.

Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.

Shirling EB, Gottlieb D. Cooperative description of type cultures of Streptomyces. III. Additional species descriptions from first and second studies. Int J Syst Bacteriol 18: 279-392, 1968.

type strain

type strain